Teklacep Capital Management is a business in Boston, MA.
Company Name: | Teklacep Capital Management |
Company Classification: | |
Company Location: | 2 Liberty Square Floor 9, Boston, MA 02109 |
Telephone Number: | (617) 772-8500 |
Company Representative: | Daniel Omstead, Chief Executive Officer |
Company Url: | hqcm.com |
NAICS Number: | 5239100 |
SIC Number: | 6726 |
Market Factor: | B2B & B2C |
Begining Year: | 1986 |
Employee Amount: | 1 to 4 |
Location Category: | Single Location |
Annual Earning (USD): | $500.000.000 to $999.999.999 |
Share This Business: | |
Related Businesses: |
Putnam Health Care Long/Short Fund Lp - Suffolk, MA Synchrony Venture Management - Suffolk, MA Putnam Voyager Fund Inc - Suffolk, MA Belair Capital Fund LLC - Suffolk, MA Apex Boston Group - Suffolk, MA Global Private Equity Iii-C Limited Partnership - Suffolk, MA Global Private Equity Iv-A Limited Partnership - Suffolk, MA Putnam High Income Convertible Bond Fund - Suffolk, MA Thunderstorm Capital - Suffolk, MA |
Teklacep Capital Management is a company that has been operational since 1986, offering products or services in the industry of . For additional details of the nature of this business, it is registered under with the SIC code 6726 and under the NAICS code 5239100 ().
Teklacep Capital Management now supports a growing employee population of 1 to 4 and the business makes an estimated annual revenue of $500.000.000 to $999.999.999. The company can be reached for inquiries about BOTH market variables and other concerns by contacting Daniel Omstead, Chief Executive Officer by phone (617) 772-8500.
For added convenience and more information, Teklacep Capital Management also has a website at hqcm.com, and can be accessed and followed through the social media outlets Twitter and Facebook . Visit Teklacep Capital Management’s physical single location at 2 Liberty Square Floor 9, Suffolk, Massachusetts or locate it via the coordinates 42.3582,-71.05553.